1-11 of 11
Hyun Gyung Goh
Close
Sort by
Journal Articles

Discontinuation of Imatinib Therapy in Chronic Myeloid Leukemia Patients with Sustained Complete Molecular Response 4.5 (CMR 4.5 )

Hyun-Gyung Goh, Soo-Young Choi, Ju-Hee Bang, Soo-Hyun Kim, Eun-Jung Jang, Dongho Kim, Ji-Young Byeun, Joon Seong Park, Hyeoung-Joon Kim, Hawk Kim, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2763.
https://doi.org/10.1182/blood.V118.21.2763.2763
Published: 2011
Journal Articles

Efficacy of Nilotinib Versus High-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses to Standard-Dose Imatinib (RE-NICE Multicenter Study)

Hyun-Gyung Goh, Saengsuree Jootar, Hyeoung-Joon Kim, Sang Kyun Sohn, Joon Seong Park, Sung Hyun Kim, Dae Young Zang, Suk-Joong Oh, Soo-Young Choi, Ju-Hee Bang, Soo-Hyun Kim, Eun-Jung Jang, Sung-Eun Lee, Dongho Kim, Ji-Young Byeun, Richard C. Woodman, Tomasz Szczudlo, Hee Jung Kim, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2765.
https://doi.org/10.1182/blood.V118.21.2765.2765
Published: 2011
Journal Articles

Correlation of Molecular Response At 18 Month with Survival Benefits As Response-Related Prognostic Factor

Soo-Hyun Kim, Dongho Kim, Hyun-Gyung Goh, Soo-Young Choi, Ju-Hee Bang, Ji-Young Byeun, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2766.
https://doi.org/10.1182/blood.V118.21.2766.2766
Published: 2011
Journal Articles

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

e-blood
Helen E. White, Paul Matejtschuk, Peter Rigsby, Jean Gabert, Feng Lin, Y. Lynn Wang, Susan Branford, Martin C. Müller, Nathalie Beaufils, Emmanuel Beillard, Dolors Colomer, Dana Dvorakova, Hans Ehrencrona, Hyun-Gyung Goh, Hakim El Housni, Dan Jones, Veli Kairisto, Suzanne Kamel-Reid, Dong-Wook Kim, Stephen Langabeer, Edmond S. K. Ma, Richard D. Press, Giuliana Romeo, Lihui Wang, Katerina Zoi, Timothy Hughes, Giuseppe Saglio, Andreas Hochhaus, John M. Goldman, Paul Metcalfe, Nicholas C. P. Cross
Journal: Blood
Blood (2010) 116 (22): e111–e117.
https://doi.org/10.1182/blood-2010-06-291641
Published: 2010
Includes: Supplemental data
Journal Articles

A Review of Mutation Analysis In the TOPS Trial of Standard Dose Versus High Dose IM In CML Suggests That Refinements to the ELN Recommendations for Mutation Screening May Be Appropriate

Susan Branford, PhD, Hyun-Gyung Goh, Barbara Izzo, Lan Beppu, Christine-Elke Ortmann, Kamila Duniec, PhD, Yu Jin, Richard C. Woodman, MD, Fabrizio Pane, MD, Dong-Wook Kim, Jerald P. Radich, MD, Timothy P. Hughes
Journal: Blood
Blood (2010) 116 (21): 889.
https://doi.org/10.1182/blood.V116.21.889.889
Published: 2010
Journal Articles

Mutation Analysis of BCR-ABL Tyrosine Kinase Domain In New Chronic Phase-Chronic Myeloid Leukemia Patients with Suboptimal Response or Treatment Failure From Imatinib Treatment.

Dong-Wook Kim, MD, Dongho Kim, Soo-Hyun Kim, Hyun-Gyung Goh, Fabrizio Pane, Timothy Hughes, Jerald P. Radich, Peter Lin, Giuseppe Saglio, Susan Branford, Giovanni Martinelli, Simona Soverini, Andreas Hochhaus
Journal: Blood
Blood (2010) 116 (21): 3441.
https://doi.org/10.1182/blood.V116.21.3441.3441
Published: 2010
Journal Articles

Dynamics and Characteristics of BCR-ABL Multiple Mutations In Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia.

Dong-Wook Kim, Dongho Kim, Soo-Hyun Kim, Saengsuree Jootar, Hyun-Gyung Goh, Jeong Lee, Soo-Young Choi, Young-Seok Lee, Sang-Mi Oh
Journal: Blood
Blood (2010) 116 (21): 3443.
https://doi.org/10.1182/blood.V116.21.3443.3443
Published: 2010
Journal Articles

Monitoring of Dynamics of BCR-ABL Transcripts Over Time Using Digital PCR Assay In CP CML Patients After Achieving Complete Molecular Remission

Hyun-Gyung Goh, Dongho Kim, Soo-Young Choi, Soo-Hyun Kim, Jeong Lee, Young-Seok Lee, Sang-Mi Oh, Dong-Wook Kim, MD
Journal: Blood
Blood (2010) 116 (21): 1726.
https://doi.org/10.1182/blood.V116.21.1726.1726
Published: 2010
Journal Articles

Impact of Baseline BCR-ABL Transcript Levels on the Response to Imatinib In CP CML Patients

Hyun-Gyung Goh, Dongho Kim, Soo-Young Choi, Soo-Hyun Kim, Jeong Lee, Young-Seok Lee, Sang-Mi Oh, Dong-Wook Kim, MD
Journal: Blood
Blood (2010) 116 (21): 1240.
https://doi.org/10.1182/blood.V116.21.1240.1240
Published: 2010
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia Who Recieved an Intermittent Imatinib Therapy.

Hyun-Gyung Goh, MS, Soo-Hyun Kim, BA, Jeong Lee, MS, Sae-Eun Jang, BA, Wan-Seok Kim, PhD, Yoo-Li Kim, MS, Sa-Hee Park, BA, Il-Young Kwon, BA, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1034.
https://doi.org/10.1182/blood.V110.11.1034.1034
Published: 2007
Journal Articles

Clinical Characteristics and Outcome of 20 Imatinib Mesylate Resistant Patients with T315I BCR-ABL Mutation.

Wan-Seok Kim, PhD, Il-Young Kweon, Soo Hyun Kim, Hyun Gyung Goh, Jeong Lee, Se Eun Jung, Dongho Kim, PhD, Sa-Hee Park, Ji-Sun Lim, Ha-Na Kim, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1954.
https://doi.org/10.1182/blood.V110.11.1954.1954
Published: 2007